W7W-16289-56267
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 914 / CA
- Registered
- 2021-07-17
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
KUE-29496-81316
Child or adolescent in my care · Female · 2021-07-17
XPL-15317-49570
Child or adolescent in my care · Female · 2021-12-29
Timeline
-
2021-07-16
Dose 1 — Pfizer-BioNTech
-
2021-07-17
Registered in v-safe
-
2021-07-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-07-19
- 2021-07-20
- 2021-07-23
- 2021-07-26
- 2021-08-01
-
2021-08-06
Dose 2 — Pfizer-BioNTech
- 2021-08-15
-
2021-08-24
Survey response — day 14, dose 2MedDRA: Food intolerance, Muscle rupture, Myalgia — Feeling: GoodFree text: Muscle pain like a tearing sensation. Sensitivity to regular foodsMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-27
- 2021-09-03
- 2021-09-10
- 2021-09-19
- 2022-02-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-16 | Pfizer-BioNTech | No |
| 2 | 2021-08-06 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Muscle pain like a tearing sensation. Sensitivity to regular foods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Food intolerance | ✓ | · | ✓ |
| SD | Muscle rupture | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release